FDA — authorised 3 October 1980
- Marketing authorisation holder: B BRAUN
- Status: approved
🇺🇸 Bss in United States
FDA authorised Bss on 3 October 1980
Marketing authorisations
FDA — authorised 28 January 2022
- Application: ANDA091387
- Marketing authorisation holder: B BRAUN
- Indication: Manufacturing (CMC)
- Status: approved
Bss in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Bss approved in United States?
Yes. FDA authorised it on 3 October 1980; FDA authorised it on 28 January 2022.
Who is the marketing authorisation holder for Bss in United States?
B BRAUN holds the US marketing authorisation.